医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| 双脱乙基氯喹 | N,N-Dideethylchloroquine | 4298-14-0 | C14H18ClN3 |
| 双硫氧吡啶 | 2,2'-dipyridyl disulfide bis-N-oxide | 3696-28-4 | C10H8N2O2S2 |
| 双环己酮乙二醇单缩酮 | 4-(1,4-dioxaspiro[4.5]decan-8-yl)cyclohexanone | 56309-94-5 | C14H22O3 |
| 双环丙基甲胺 | dicyclopropylmethylamine | 13375-29-6 | C7H13N |
| 双环[2.2.2]辛烷-7-醇 | bicyclo[2.2.2]octan-2-ol | 18684-63-4 | C8H14O |
| 双环[2.2.2]辛烷-1,4-二羧酸二甲酯 | dimethyl bicyclo[2.2.2]octane-1,4-dicarboxylate | 1459-96-7 | C12H18O4 |
| 双环[1.1.1]戊烷-1,3-二甲酸 | bicyclo[1.1.1]pentane-1,3-dicarboxylic acid | 56842-95-6 | C7H8O4 |
| 双吲哚马来酰亚胺 V | bisindolylmaleimide V | 113963-68-1 | C21H15N3O2 |
| 双吲哚马来酰亚胺 IV | 3,4-bis(3-indolyl)-1H-pyrrole-2,5-dione | 119139-23-0 | C20H13N3O2 |
| 双吗啉甲烷 | 4-(morpholinomethyl)morpholine | 5625-90-1 | C9H18N2O2 |
| 双五亚甲基尿素 | 1,1'-carbonyldipiperidine | 5395-04-0 | C11H20N2O |
| 双乙酰阿昔洛韦 | 2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one | 75128-73-3 | C12H15N5O5 |
| 双-(2-甲氧基苯基)磷氧化物(MPPO) | Phosphine oxide, bis(2-methoxyphenyl)- | 71360-04-8 | C14H14O3P+ |
| 双(吡啶-3-基)-4H-1,2,4-三唑-4-胺 | 4-amino-3,5-bis(3-pyridyl)-1,2,4-triazole | 38629-66-2 | C12H10N6 |
| 双(吡啶)碘四氟化硼 | Bis(pyridine)iodonium tetrafluoroborate | 15656-28-7 | C10H12BF4IN2 |
| 双(9,9-二甲基-9H-芴-2-基)胺 | bis(9,9-dimethyl-9H-fluoren-2-yl)amine | 500717-23-7 | C30H27N |
| 双(4-异丙苯基)氯化碘鎓 | bis(4-isopropylphenyl)iodonium chloride | 97671-66-4 | C18H22I*Cl |
| 双(4-(2,4,4-三甲基-2-戊基)苯基)胺 | bis(4-(2,4,4-trimethylpentan-2-yl)phenyl)amine | 15721-78-5 | C28H43N |
| 双(4,6-二氟苯基吡啶-N,C2)吡啶甲酰合铱 | Bis[2-(4,6-difluorophenyl)pyridinato-C2,N](picolinato)iridium(III) | 376367-93-0 | C28H16F4IrN3O2 |
| 双(3-甲氧基苯基)胺 | bis(3-methoxyphenyl)amine | 92248-06-1 | C14H15NO2 |
| 双(2-羟乙基)氨基(三羟甲基)甲烷盐酸盐 | 2-(Bis(2-hydroxyethyl)amino)-2-(hydroxymethyl)propane-1,3-diol hydrochloride | 124763-51-5 | C8H20ClNO5 |
| 双(2-噻吩)酮 | di(thiophen-2-yl)methanone | 704-38-1 | C9H6OS2 |
| 双(2-噻吩)甲肟 | bis(2-thienyl)methanone oxime | 10558-44-8 | C9H7NOS2 |
| 双(2,4,6-三甲基吡啶)碘(I)六氟磷酸盐 | Bis(2,4,6-trimethylpyridine)iodonium Hexafluorophosphate | 113119-46-3 | C16H20F6IN2P |
| 双(2,4,6-三甲基吡啶)溴代六氟磷酸盐 | Bis(2,4,6-trimethylpyridine)bromonium Hexafluorophosphate | 188944-77-6 | C16H22BrF6N2P |
| 双(10-羟基苯并[h]喹啉)铍 | bis(10-hydroxybenzo[h]quinolinato)beryllium | 148896-39-3 | C26H16BeN2O2 |
| 双(1-甲基吡啶-4-氨) | Bis(1-methylpiperidin-4-yl)amine | 117927-28-3 | C12H25N3 |
| 双((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)甲烷 | 2,2-methylene-[(4R)-3,5-tert-butylphenyl-2-oxazoline] | 131833-91-5 | C15H26N2O2 |
| 去甲肾上腺素酒石酸盐 | (+/-)-noradrenaline bitartrate | 3414-63-9 | C4H6O6*C8H11NO3 |
| 去甲氨噻肟酸乙酯 | (Z)-ethyl 2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetate | 64485-82-1 | C7H9N3O3S |
| 去甲氨噻肟酸 | 2-(2-aminothiazole-4-yl)-2-(syn)-hydroxyiminoacetic acid | 66338-96-3 | C5H5N3O3S |
| 去氧拉巴醌 | deoxylapachol | 3568-90-9 | C15H14O2 |
| 去乙基胺碘酮 | desethylamiodarone | 83409-32-9 | C23H25I2NO3 |
| 原烟碱 | nornicotine | 494-97-3 | C9H12N2 |
| 原栎醇 | (+)-proto-quercitol | 488-73-3 | C6H12O5 |
| 卡非佐米中间体 | (S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenyipropanoic acid | 868540-16-3 | C31H42N4O6 |
| 卡玛替尼N-6 | 6-((2-(4-bromo-3-fluorophenyl)imidazo[1,2-b][1,2,4]triazin-7-yl)methyl)quinoline | 1029714-86-0 | C21H13BrFN5 |
| 卡格列净中间体 | (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol | 866607-35-4 | C32H33FO9S |
| 卡帕诺生 | Capadenoson | 544417-40-5 | C25H18ClN5O2S2 |
| 卡巴折伦 | Carbazeran | 70724-25-3 | C18H24N4O4 |
| 卡培他滨杂质N | [(2R,3R,4R,5R)-2-[5-Fluoro-2-oxo-4-(pentoxycarbonylamino)pyrimidin-1-yl]-4-hydroxy-5-methyloxolan-3-yl] acetate | 1262133-69-6 | C17H24FN3O7 |
| 卡培他滨中间体6 | pentyl (5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate | 862508-03-0 | C10H14FN3O3 |
| 卡博特韦钠盐 | (3S,11aR)-N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide sodium salt | 1051375-13-3 | C19H16F2N3O5*Na |
| 博舒替尼一水化合物 | bosutinib monohydrate | 918639-08-4 | C26H29Cl2N5O3*H2O |
| 十氢异喹啉-6-醇 | Decahydroisoquinolin-6-ol | 725228-44-4 | C9H17NO |
| 十氢异喹啉 | Decahydro-pyrazino<2,3-b>pyrazin | 5409-42-7 | C6H14N4 |
| 十氢异喹啉 | decahydroisoquinoline | 6329-61-9 | C9H17N |
| 十氢喹啉-4-羧酸 | decahydroquinoline-4-carboxylic acid | 13337-72-9 | C10H17NO2 |
| 十氢喹啉 | decahydroquinoline | 2051-28-7 | C9H17N |
| 十四烷基硫代乙酸 | tetradecylthioacetic Acid | 2921-20-2 | C16H32O2S |